Partnerships

Since our inception, we have been dedicated to innovation in the rapidly expanding therapeutic botulinum toxin market. Our comprehensive product assessment process is backed by decades of commercial neurotoxin expertise and designed to identify indications in which ABP-450 can achieve clinical, regulatory, and commercial success.

As we continue to evaluate additional therapeutic indications for development, we seek partners who are invested in our mission to deliver the full potential of therapeutic neurotoxins to patients with a range of neuromuscular conditions.

To learn more about partnering with AEON, please reach out to our team using our contact form.